Supplemental material
Journal of Enzyme Inhibition and Medicinal Chemistry
Volume 33, 2018 - Issue 1
Articles
Design, synthesis, and screening of ortho-amino thiophene carboxamide derivatives on hepatocellular carcinomaas VEGFR-2Inhibitors
, , 
, &
Ahmed T. NegmeldinPharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt; ;Department of Pharmaceutical Sciences College of Pharmacy, Gulf Medical University, Gulf Medical University, Ajman, UAE; Correspondence[email protected]
http://orcid.org/0000-0003-3399-3435
http://orcid.org/0000-0003-3399-3435, & Related Research Data
Mechanisms of acquired resistance to tyrosine kinase inhibitors
Source:
Production and hosting by Elsevier B.V.
Substituierte 3,4‐Diamino‐thieno[2,3‐b]pyrrole
Source:
Wiley
Design, synthesis and cytotoxic activity of certain novel chalcone analogous compounds.
Source:
Elsevier BV
An Integrated Approach to Fragment-Based Lead Generation:Philosophy, Strategy and Case Studies from AstraZenecas Drug Discovery Programmes
Source:
Bentham Science Publishers Ltd.
A novel Chk inhibitor, XL-844, increases human cancer cell radiosensitivity through promotion of mitotic catastrophe
Source:
Springer Science and Business Media LLC
Tubulin-interactive stilbene derivatives as anticancer agents
Source:
Walter de Gruyter GmbH
New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening
Source:
Oxford University Press (OUP)
Discovery of novel non-ATP competitive FGFR1 inhibitors and evaluation of their anti-tumor activity in non-small cell lung cancer in vitro and in vivo
Source:
Impact Journals, LLC
Combination therapy in cancer: effects of angiogenesis inhibitors on drug pharmacokinetics and pharmacodynamics
Source:
Springer Nature
Third-Generation Tyrosine Kinase Inhibitors Targeting Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer.
Source:
Frontiers Media SA
MDA mechanisms of action
Source:
Wiley
Ligands of the colchicine site of tubulin: A common pharmacophore and new structural classes
Source:
Springer Science and Business Media LLC
Sorafenib-based combined molecule targeting in treatment of hepatocellular carcinoma.
Source:
Baishideng Publishing Group Inc.
A common pharmacophore for a diverse set of colchicine site inhibitors using a structure-based approach.
Source:
American Chemical Society (ACS)
First-in-human phase I trial of two schedules of OSI-930, a novel multikinase inhibitor, incorporating translational proof-of-mechanism studies.
Source:
American Association for Cancer Research (AACR)
Synthesis of pyrimido[4,5-e][1,4]oxazepin-5-ones
Source:
Wiley
Synthesis and Chemical Characterisation of New Bis-Thieno (2,3-b)thiophene Derivatives
Source:
Molecular Diversity Preservation International
First- and Second-Line Targeted Systemic Therapy in Hepatocellular Carcinoma—An Update on Patient Selection and Response Evaluation
Source:
MDPI AG
Background of QSAR and Historical Developments
Source:
Elsevier
An Overview of Tubulin Inhibitors That Interact with the Colchicine Binding Site
Source:
Springer Science and Business Media LLC
Targeted systemic therapies for hepatocellular carcinoma: clinical perspectives, challenges and implications.
Source:
Baishideng Publishing Group Inc.
Design and synthesis of thienopyrimidine urea derivatives with potential cytotoxic and pro-apoptotic activity against breast cancer cell line MCF-7.
Source:
Elsevier BV
Molecular Modeling Approaches to Study the Binding Mode on Tubulin of Microtubule Destabilizing and Stabilizing Agents
Source:
Springer Berlin Heidelberg
Small-Molecule Inhibitors of the Receptor Tyrosine Kinases: Promising Tools for Targeted Cancer Therapies
Source:
MDPI AG
Structure-based and shape-complemented pharmacophore modeling for the discovery of novel checkpoint kinase 1 inhibitors
Source:
Springer Science and Business Media LLC
Alternative energy sources for green chemistry
Source:
Royal Society of Chemistry
Linking provided by
